Immune signature for papillary RCC predicts outcomes

A recent study published in Cancer Medicine has identified immune-related genes that correlate with overall survival in patient with papillary renal cell carcinoma (RCC). Analysis of the gene profiles from samples of papillary RCC tumours identified a group of 15 immune-related genes that correlate with survival outcome. These gene profiles may help to personalise treatments for individual patients, such as immunotherapy.

Read more in Cancer Therapy Advisor here

Share this Post!


Related post

  TOP